The vial contains a white lyophilized powder
Serious but rare side effects No discussion of cagrilintide safety would be complete without addressing the serious adverse events
Subcutaneous GLP-1 injections under ~1 mL are well-tolerated
Additionally, there was prevalence of GO processes with upregulation of the gliogenic pathway and downregulation of neuronal differentiation, indicating the requirement of IMPA1 for these processes
The peptide, typically administered as a nasal spray, has shown the most promise in humans for treating neurological conditions, particularly ischemic stroke, but there is no evidence for general cognitive enhancement
Researchers at the University of Zagreb, led by Predrag Sikiric, first isolated and studied the compound, publishing decades of preclinical work on its stability and biological activity